Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation

Bax is a proapoptotic Bcl-2 family member that has a central role in the initiation of mitochondria-dependent apoptosis. However, the mechanism of Bax activation during apoptosis remains unsettled. It is believed that the activation of Bax is mediated by either dissociation from prosurvival Bcl-2 family members, or direct association with BH3-only members. Several interaction sites on Bax that mediate its interactions with other Bcl-2 family members, as well as its proapoptotic activity, have been identified in previous studies by other groups. To rigorously investigate the functional role of these interaction sites, we knocked in their respective mutants using HCT116 colon cancer cells, in which apoptosis induced by several stimuli is strictly Bax-dependent. Bax-mediated apoptosis was intact upon knock-in (KI) of K21E and D33A, which were shown to block the interaction of Bax with BH3-only activators. Apoptosis was partially reduced by KI of D68R, which impairs the interaction of Bax with prosurvival members, and S184V, a constitutively mitochondria-targeting mutant. In contrast, apoptosis was largely suppressed by KI of L70A/D71A, which blocks homo-oligomerization of Bax and its binding to prosurvival Bcl-2 family proteins. Collectively, our results suggest that the activation of endogenous Bax in HCT116 cells is dependent on its homo-oligomerization sites, but not those previously shown to interact with BH3-only activators or prosurvival proteins only. We therefore postulate that critical interaction sites yet to be identified, or mechanisms other than protein-protein interactions, need to be pursued to delineate the mechanism of Bax activation during apoptosis.

[1]  Y. Hsu,et al.  Complete activation of Bax by a single site mutation , 2007, Oncogene.

[2]  R. Youle,et al.  The role of mitochondria in apoptosis*. , 2009, Annual review of genetics.

[3]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[4]  H. Blair,et al.  PINCH-1 Regulates the ERK-Bim Pathway and Contributes to Apoptosis Resistance in Cancer Cells* , 2008, Journal of Biological Chemistry.

[5]  Y. Hsu,et al.  Conformation of the Bax C‐terminus regulates subcellular location and cell death , 1999, The EMBO journal.

[6]  C. Gélinas,et al.  Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB , 2001, Nature Cell Biology.

[7]  S. Korsmeyer,et al.  The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. , 2000, Molecular cell.

[8]  N. Tjandra,et al.  BAX Activation is Initiated at a Novel Interaction Site , 2008, Nature.

[9]  S. Cory,et al.  The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.

[10]  Erinna F. Lee,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax , 2008 .

[11]  Jian Yu,et al.  The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage , 2007, Proceedings of the National Academy of Sciences.

[12]  Jian Yu,et al.  NSAIDs Downregulate Bcl-XL and Dissociate BAX and Bcl-XL to Induce Apoptosis in Colon Cancer Cells , 2008, Nutrition and cancer.

[13]  P. Colman,et al.  To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. , 2008, Molecular cell.

[14]  D. Hancock,et al.  Identification of Novel Isoforms of the BH3 Domain Protein Bim Which Directly Activate Bax To Trigger Apoptosis , 2002, Molecular and Cellular Biology.

[15]  Z. Weng,et al.  Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies , 2008, Nature Methods.

[16]  X. Wang.  The expanding role of mitochondria in apoptosis. , 2001, Genes & development.

[17]  A. Strasser,et al.  The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.

[18]  G. Dewson,et al.  Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis , 2009, Journal of Cell Science.

[19]  K. Kinzler,et al.  SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Philippe Juin,et al.  The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. , 2004, Molecular cell.

[21]  T. Burns,et al.  Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. , 2001, The Journal of biological chemistry.

[22]  D. Andrews,et al.  Still embedded together binding to membranes regulates Bcl-2 protein interactions , 2010, Oncogene.

[23]  D. Green,et al.  A unified model of mammalian BCL-2 protein family interactions at the mitochondria. , 2011, Molecular cell.

[24]  Osamu Takeuchi,et al.  Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. , 2009, Molecular cell.

[25]  Y. Hsu,et al.  Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Jian Yu,et al.  Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. , 2011, Cancer research.

[27]  J. Hickman,et al.  Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members , 2009, The Journal of cell biology.

[28]  Xu Luo,et al.  A three-helix homo-oligomerization domain containing BH3 and BH1 is responsible for the apoptotic activity of Bax. , 2007, Genes & development.

[29]  J. Hsieh,et al.  Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies , 2006, Nature Cell Biology.

[30]  K. Kinzler,et al.  Role of BAX in the apoptotic response to anticancer agents. , 2000, Science.

[31]  K. Kinzler,et al.  PUMA mediates the apoptotic response to p53 in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Peng Wang,et al.  PUMA Dissociates Bax and Bcl-XL to Induce Apoptosis in Colon Cancer Cells* , 2006, Journal of Biological Chemistry.

[33]  Osamu Takeuchi,et al.  BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program , 2010, Science.

[34]  Jian Yu,et al.  Chemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis , 2010, Proceedings of the National Academy of Sciences.

[35]  D. Green,et al.  The Pathophysiology of Mitochondrial Cell Death , 2004, Science.

[36]  R. Youle,et al.  Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1’s inhibitory effect on Bak , 2011, Oncogene.

[37]  P. Bouillet,et al.  BH3-only proteins and their roles in programmed cell death , 2008, Oncogene.

[38]  Erinna F. Lee,et al.  Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak , 2007, Science.

[39]  Jian Yu,et al.  Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth , 2011, Oncogene.

[40]  S. Korsmeyer,et al.  Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis , 1998, The EMBO journal.

[41]  Peter Schow,et al.  Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax , 2002, Nature Medicine.